Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 215

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 215
---
 be increased, the exercise period could be shortened and the number of ordinary shares purchasable upon exercise of a Warrant could be decreased, all without your approval. The APx Warrants are issued in registered form under the SPAC Warrant Agreement, which provides that the terms of the APx Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants. Accordingly, APx may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 65% of the then outstanding Public Warrants approve of such amendment. Although APx’s ability to amend the terms of the Public Warrants with the consent of at least 65% of the then outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the APx Warrants, convert the APx Warrants into cash or shares (at a ratio different than initially provided), shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise of an APx Warrant. APx may redeem your unexpired APx Warrants prior to their exercise at a time that is disadvantageous to you, thereby making your APx Warrants worthless. APx has the ability to redeem all of the outstanding APx Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per APx Warrant; provided that the closing price of the Public Shares equals or exceeds $18.00 per share (as adjusted for share subdivision, share capitalizations, reorganizations, recapitalizations and the like and for certain issuances of equity and equity -linkedsecurities for capital raising purposes in connection with the closing of the Business Combination as described elsewhere in this proxy statement/prospectus) for any 20 trading days within a 30 trading -dayperiod ending on the third trading day prior to proper notice of such redemption, provided that on the date, APx gives notice of redemption. APx will not redeem the APx Warrants unless an effective registration statement under the Securities Act covering the shares issuable upon exercise of the APx Warrants is effective and a current prospectus relating to those ordinary shares is available throughout the 30 -dayredemption period, except if the APx